Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 10435438 Modulation of complement activity

Patent 10435438 was granted and assigned to Ra Pharmaceuticals on October, 2019 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

Patent

Patent attributes

Patent Applicant

Ra Pharmaceuticals

Current Assignee

Ra Pharmaceuticals

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

10435438

Patent Inventor Names

Daniel Elbaum0

Sarah Jacqueline Perlmutter0

Zhaolin Wang0

Zhong Ma0

Alonso Ricardo0

Douglas A. Treco0

Guo-Qing Tang0

Hong Zheng0

...

Date of Patent

October 8, 2019

Patent Application Number

16237893

Date Filed

January 2, 2019

Patent Citations Received

‌

US Patent 11014965 Modulation of complement activity

‌

US Patent 11965040 Modulation of complement activity

‌

US Patent 11752190 Modulators of complement activity

‌

US Patent 11535650 Modulation of complement activity

‌

US Patent 10918691 Modulators of complement activity

‌

US Patent 11707503 Modulators of complement activity

Patent Primary Examiner

‌

Jeanette M Lieb

Patent abstract

The present invention provides modulators of complement activity. Also provided are methods of utilizing such modulators as therapeutics.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 10435438 Modulation of complement activity

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Access by API